These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27052817)

  • 21. Baloxavir vs oseltamivir: reduced utilization and costs in influenza.
    Neuberger E; Wallick C; Chawla D; Castro RC
    Am J Manag Care; 2022 Mar; 28(3):e88-e95. PubMed ID: 35404552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study.
    Nordstrom BL; Oh K; Sacks ST; L'Italien GJ
    Antivir Ther; 2004 Apr; 9(2):187-95. PubMed ID: 15134180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs.
    Wallick C; Wu N; To TM; Keebler D; Moawad D
    J Med Econ; 2021; 24(1):386-393. PubMed ID: 33571032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases.
    Casscells SW; Granger E; Kress AM; Linton A; Madjid M; Cottrell L
    Circ Cardiovasc Qual Outcomes; 2009 Mar; 2(2):108-15. PubMed ID: 20031822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective surveillance of antiviral resistance in hospitalized infants less than 12 months of age with A(H3N2) influenza infection and treated with oseltamivir.
    Rath B; Chen X; Spies V; Muehlhans S; Obermeier P; Tief F; Seeber L; Karsch K; Milde J; Skopnik H; Schweiger B; Duwe SC
    Antivir Ther; 2017; 22(6):515-522. PubMed ID: 28205506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS).
    Fraaij PL; Schutten M; Javouhey E; Burleigh L; Outlaw R; Kumar D; Boucher CA
    Antivir Ther; 2015; 20(6):633-42. PubMed ID: 25849228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza.
    Casscells SW; Granger E; Kress AM; Linton A
    Int J Adolesc Med Health; 2009; 21(1):79-89. PubMed ID: 19526698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.
    Blumentals WA; Song X
    MedGenMed; 2007 Oct; 9(4):23. PubMed ID: 18311373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama.
    Dawood FS; Jara J; Gonzalez R; Castillo JM; De León T; Estripeaut D; Luciani K; Sujey Brizuela Y; Barahona A; Cazares RA; Lawson AM; Rodriguez M; de Viana D; Franco D; Castillo M; Fry AM; Gubareva L; Tamura D; Hughes M; Gargiullo P; Clara W; Azziz-Baumgartner E; Widdowson MA
    Antiviral Res; 2016 Sep; 133():85-94. PubMed ID: 27451343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Temporal Patterns and Patient Factors Associated With Oseltamivir Administration in Children Hospitalized With Influenza, 2007-2020.
    Walsh PS; Schnadower D; Zhang Y; Ramgopal S; Shah SS; Wilson PM
    JAMA Netw Open; 2022 Sep; 5(9):e2233027. PubMed ID: 36149655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data.
    Htoo PT; Measer G; Orr R; Bohn J; Sorbello A; Francis H; Dutcher SK; Cosgrove A; Carruth A; Toh S; Cocoros NM
    Am J Epidemiol; 2022 Mar; 191(5):908-920. PubMed ID: 35106530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes.
    Katzen J; Kohn R; Houk JL; Ison MG
    Clin Infect Dis; 2019 Jun; 69(1):52-58. PubMed ID: 30304487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical features and outcome of 2009 H1N1 influenza in the pediatric setting. Multicenter prospective study in the ED].
    Desmoulins C; Michard-Lenoir AP; Naud J; Claudet I; Nouyrigat V; Chéron G
    Arch Pediatr; 2011 May; 18(5):505-11. PubMed ID: 21458977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oseltamivir treatment for influenza in hospitalized children without underlying diseases.
    Bueno M; Calvo C; Méndez-Echevarría A; de José MI; Santos M; Carrasco J; Tovizi M; Guillén S; de Blas A; Llorente M; Tarrago A; Escosa L; Cilleruelo MJ; Tomatis C; Blazquez D; Otheo E; Mazagatos D; García-García ML
    Pediatr Infect Dis J; 2013 Oct; 32(10):1066-9. PubMed ID: 23722530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outpatient influenza antivirals in a distributed data network for influenza surveillance.
    Cocoros NM; Panucci G; Haug N; Maher C; Reichman M; Toh S
    Influenza Other Respir Viruses; 2018 Nov; 12(6):804-807. PubMed ID: 30053342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry.
    Adisasmito W; Chan PK; Lee N; Oner AF; Gasimov V; Aghayev F; Zaman M; Bamgboye E; Dogan N; Coker R; Starzyk K; Dreyer NA; Toovey S
    J Infect Dis; 2010 Oct; 202(8):1154-60. PubMed ID: 20831384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for hospitalization among children with influenza B infection.
    Moolasart V; Manosuthi W
    Southeast Asian J Trop Med Public Health; 2014 May; 45(3):622-9. PubMed ID: 24974646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals.
    Best JH; Reddy SR; Chang E; Bognar K; Tarbox MH; Cagas SE; Seetasith A
    J Med Econ; 2024; 27(1):240-252. PubMed ID: 38294309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.